Abstract
Recent studies indicated that andrographolide was a potential anti-HIV therapeutic agent. In the paper, the synthesis of a series of andrographolide derivatives was described and their anti-HIV activities were evaluated in vitro. As compared with TI, compounds 5c, 5d and 5i showed moderate inhibitory activities on the cytopathic effect with TI above 10. Among the derivatives, compound 5i was the best one with TI > 51.
Keywords: Andrographolide, anti-HIV, derivatives, synthesis, cytopathic effect, HIV/AIDS, alkaloids, polysaccharides, flavonoids, triterpenes, lactones, sapon-ins, Andrographis paniculata, protein-mediated syncytia, HL60 cells, CD4+ lymphocyte level, HIV-1 RNA, lipopoly-saccharides (LPS)-induced tumor necrosis factor, interleukin-6, cyclooxygenase-2, acid anhydride, DMAP, CH2Cl2, propionic anhydride, hexanoic anhydride, benzoyl chloride, triphenylchloromethane, methylmorpholine, dicyclohexylcarbodiimide, C8166 cells, therapeutic index, anti-HIV-1 effects, hin-layer chromatography, DMSO, fetal bovine serum, 96-well microtiter plate, HIV-1 tissue culture infections dose
Medicinal Chemistry
Title: Synthesis and Preliminary Anti-HIV Activities of Andrographolide Derivatives
Volume: 6 Issue: 4
Author(s): Bin Wang, Liang Ge, Wenlong Huang, Huibin Zhang, Hai Qian, Jing Li and Yongtang Zheng
Affiliation:
Keywords: Andrographolide, anti-HIV, derivatives, synthesis, cytopathic effect, HIV/AIDS, alkaloids, polysaccharides, flavonoids, triterpenes, lactones, sapon-ins, Andrographis paniculata, protein-mediated syncytia, HL60 cells, CD4+ lymphocyte level, HIV-1 RNA, lipopoly-saccharides (LPS)-induced tumor necrosis factor, interleukin-6, cyclooxygenase-2, acid anhydride, DMAP, CH2Cl2, propionic anhydride, hexanoic anhydride, benzoyl chloride, triphenylchloromethane, methylmorpholine, dicyclohexylcarbodiimide, C8166 cells, therapeutic index, anti-HIV-1 effects, hin-layer chromatography, DMSO, fetal bovine serum, 96-well microtiter plate, HIV-1 tissue culture infections dose
Abstract: Recent studies indicated that andrographolide was a potential anti-HIV therapeutic agent. In the paper, the synthesis of a series of andrographolide derivatives was described and their anti-HIV activities were evaluated in vitro. As compared with TI, compounds 5c, 5d and 5i showed moderate inhibitory activities on the cytopathic effect with TI above 10. Among the derivatives, compound 5i was the best one with TI > 51.
Export Options
About this article
Cite this article as:
Wang Bin, Ge Liang, Huang Wenlong, Zhang Huibin, Qian Hai, Li Jing and Zheng Yongtang, Synthesis and Preliminary Anti-HIV Activities of Andrographolide Derivatives, Medicinal Chemistry 2010; 6 (4) . https://dx.doi.org/10.2174/1573406411006040252
DOI https://dx.doi.org/10.2174/1573406411006040252 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Clinical Significance of Thiopurine S-Methyltransferase Gene Polymorphisms
Current Pharmacogenomics Natural Sesquiterpene Lactones in the Prevention and Treatment of Inflammatory Disorders and cancer: A Systematic Study of this Emerging Therapeutic Approach based on Chemical and Pharmacological Aspect
Letters in Drug Design & Discovery The Quinolone Family: From Antibacterial to Anticancer Agents
Current Medicinal Chemistry - Anti-Cancer Agents The Role of Intracrine Androgen Metabolism, Androgen Receptor and Apoptosis in the Survival and Recurrence of Prostate Cancer During Androgen Deprivation Therapy
Current Drug Targets Vascular Endothelial Growth Factor and Its Receptor as Drug Targets in Hematological Malignancies
Current Drug Targets Recent Advances in Small Molecule Prodrugs for Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Virulence Factors of Helicobacter pylori: Practical Biomarkers
Recent Patents on Biomarkers Tumor Vasculature Targeting Through NGR Peptide-Based Drug Delivery Systems
Current Pharmaceutical Biotechnology <i>In Vitro</i> Anti-proliferative Properties of Flavonoids Isolated from <i>Artocarpus Heterophyllus</i> on Cancer Cell Lines
The Natural Products Journal The Frequency of Thrombotic Events Among Adults Given Antifibrinolytic Drugs for Spontaneous Bleeding: Systematic Review and Meta-Analysis of Observational Studies and Randomized Trials
Current Drug Safety Therapeutic Targets in Triple Negative Breast Cancer - Where are we now?
Recent Patents on Anti-Cancer Drug Discovery Self-Adjuvanting Lipopeptide Vaccines
Current Medicinal Chemistry Current Bioactive Azole-Containing Natural Products
Current Bioactive Compounds Paclitaxel Formulations: Challenges and Novel Delivery Options
Current Drug Delivery KIR Molecules: Recent Patents of Interest for the Diagnosis and Treatment of Several Autoimmune Diseases, Chronic Inflammation, and B-cell Malignancies
Recent Patents on DNA & Gene Sequences Stem Cell Transplantation for Chronic Myeloid Leukemia (CML): Current Indications and Perspectives
Current Cancer Drug Targets Withdrawal Notice: Circulatory Cells as Tumortropic Carrier for Targetability Improvement
Current Drug Delivery Beclin 1 Biology and its Role in Heart Disease
Current Cardiology Reviews mTOR Inhibitors in Tuberous Sclerosis Complex
Current Neuropharmacology Nanomedicine as a Strategy for Natural Compound Delivery to Prevent and Treat Cancers
Current Pharmaceutical Design